New Weight Loss Pen | Wegovy Injections for Weight Loss

by in Body Lab May 17, 2022

The FDA recently approved a new weight loss pen for use in the United States. This injection is for chronic weight management in obese adults. It can help adults achieve weight loss with a once-a-week injection.

Weight Loss Pen

Wegovy, semaglutide, is the first approved drug for chronic weight management in adults with obesity since 2014. It is for patients with obesity or patients who are overweight and suffer from at least one weight related problem like high blood pressure, type 2 diabetes, or high cholesterol. This weight loss pen combined with a reduced caloric intake and increased physical activity can help patients lose weight and maintain weight loss goals.

How Wegovy Works

weight loss pen

Wegovy mimics a hormone called glucagon-like peptide-1 (GLP-1). The body releases this hormone after eating. It targets areas of the brain that regulate appetite and food intake. The injection makes patients feel fuller, so they consume fewer calories. In turn, the patient can lose weight.

Clinical Trials

This new weight loss pen has been studied in four 68-week trials. One study in 2021 consisted of 1,961 adults with a BMI over 30. The treatment group self-administer weekly injections of 2.4 mg of semaglutide. The control group received a placebo in the same way. All participants followed a reduced calorie diet and increased physical activity. They also received counseling sessions every 4 weeks to help maintain lifestyle changes.

Significant Results with New Weight Loss Pen

In the treatment group, participants lost on average, 14.9% of their body mass over the course of the trial. Those receiving the placebo reduced their weight by 2.4%. Additionally, over half of the those in the treatment group lose more than 15% of their body weight.

Weight Loss Pen Near Me

If you are tired of struggling with obesity, Wegovy might be right for you. Please contact Reston Dermatology to learn more.